rs1137933

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_000625.4(NOS2):​c.1155C>T​(p.Asp385=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 1,606,554 control chromosomes in the GnomAD database, including 38,212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 3380 hom., cov: 31)
Exomes 𝑓: 0.22 ( 34832 hom. )

Consequence

NOS2
NM_000625.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.631
Variant links:
Genes affected
NOS2 (HGNC:7873): (nitric oxide synthase 2) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 17-27778906-G-A is Benign according to our data. Variant chr17-27778906-G-A is described in ClinVar as [Benign]. Clinvar id is 2688251.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.631 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NOS2NM_000625.4 linkuse as main transcriptc.1155C>T p.Asp385= synonymous_variant 10/27 ENST00000313735.11 NP_000616.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NOS2ENST00000313735.11 linkuse as main transcriptc.1155C>T p.Asp385= synonymous_variant 10/271 NM_000625.4 ENSP00000327251 P2P35228-1

Frequencies

GnomAD3 genomes
AF:
0.207
AC:
31426
AN:
151852
Hom.:
3380
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.179
Gnomad AMI
AF:
0.444
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.188
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.227
GnomAD3 exomes
AF:
0.205
AC:
50930
AN:
248726
Hom.:
5521
AF XY:
0.209
AC XY:
28148
AN XY:
134414
show subpopulations
Gnomad AFR exome
AF:
0.179
Gnomad AMR exome
AF:
0.142
Gnomad ASJ exome
AF:
0.277
Gnomad EAS exome
AF:
0.168
Gnomad SAS exome
AF:
0.194
Gnomad FIN exome
AF:
0.210
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.225
GnomAD4 exome
AF:
0.216
AC:
314117
AN:
1454584
Hom.:
34832
Cov.:
34
AF XY:
0.216
AC XY:
156003
AN XY:
722268
show subpopulations
Gnomad4 AFR exome
AF:
0.179
Gnomad4 AMR exome
AF:
0.145
Gnomad4 ASJ exome
AF:
0.272
Gnomad4 EAS exome
AF:
0.117
Gnomad4 SAS exome
AF:
0.192
Gnomad4 FIN exome
AF:
0.208
Gnomad4 NFE exome
AF:
0.224
Gnomad4 OTH exome
AF:
0.212
GnomAD4 genome
AF:
0.207
AC:
31432
AN:
151970
Hom.:
3380
Cov.:
31
AF XY:
0.207
AC XY:
15353
AN XY:
74260
show subpopulations
Gnomad4 AFR
AF:
0.179
Gnomad4 AMR
AF:
0.189
Gnomad4 ASJ
AF:
0.273
Gnomad4 EAS
AF:
0.166
Gnomad4 SAS
AF:
0.188
Gnomad4 FIN
AF:
0.216
Gnomad4 NFE
AF:
0.224
Gnomad4 OTH
AF:
0.224
Alfa
AF:
0.197
Hom.:
1597
Bravo
AF:
0.206
Asia WGS
AF:
0.152
AC:
527
AN:
3478
EpiCase
AF:
0.231
EpiControl
AF:
0.225

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. -
NOS2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 22, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
2.9
DANN
Benign
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1137933; hg19: chr17-26105932; COSMIC: COSV58222552; API